On Oct 9, Elevance Health rose 3.44% in regular trading, trading at $414.05 per share with turnover of $19.60 million.

The move was driven by strength across the managed health care sector, after Humana's largest Medicare Advantage contract returned to a four-star rating, restoring its eligibility for government quality bonuses. Humana surged 16.24%, UnitedHealth rose 3.57%, and Centene gained 3.3%, lifting overall risk appetite. As a leading health benefits and managed care provider, Elevance Health was carried higher by the sector-wide momentum.

The company operates health plans in multiple states under Blue Cross and Blue Shield licenses and provides services to approximately 45.2 million medical members.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)